-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Unveils Positive Phase 1 Data for SAB-142 in Type 1 Diabetes Trial

Reuters·12/08/2025 13:00:31

Please log in to view news